+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma



The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma



Plos One 6(8): E23332



Gliomas are the most frequently occurring primary brain tumor in the central nervous system of adults. Glioblastoma multiformes (GBMs, WHO grade 4) have a dismal prognosis despite the use of the alkylating agent, temozolomide (TMZ), and even low grade gliomas (LGGs, WHO grade 2) eventually transform to malignant secondary GBMs. Although GBM patients benefit from promoter hypermethylation of the O(6)-methylguanine-DNA methyltransferase (MGMT) that is the main determinant of resistance to TMZ, recent studies suggested that MGMT promoter methylation is of prognostic as well as predictive significance for the efficacy of TMZ. Glioma-CpG island methylator phenotype (G-CIMP) in the global genome was shown to be a significant predictor of improved survival in patients with GBM. Collectively, we hypothesized that MGMT promoter methylation might reflect global DNA methylation. Additionally in LGGs, the significance of MGMT promoter methylation is still undetermined. In the current study, we aimed to determine the correlation between clinical, genetic, and epigenetic profiles including LINE-1 and different cancer-related genes and the clinical outcome in newly diagnosed 57 LGG and 54 GBM patients. Here, we demonstrated that (1) IDH1/2 mutation is closely correlated with MGMT promoter methylation and 1p/19q codeletion in LGGs, (2) LINE-1 methylation levels in primary and secondary GBMs are lower than those in LGGs and normal brain tissues, (3) LINE-1 methylation is proportional to MGMT promoter methylation in gliomas, and (4) higher LINE-1 methylation is a favorable prognostic factor in primary GBMs, even compared to MGMT promoter methylation. As a global DNA methylation marker, LINE-1 may be a promising marker in gliomas.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056352885

Download citation: RISBibTeXText

PMID: 21829728

DOI: 10.1371/journal.pone.0023332


Related references

MGMT Promoter-Methylation Analysis of Glioblastoma Using Illuminas Infinium HumanMethylation450K Array: Subventricularzone Infiltration and MGMT Promoter Methylation Are Independent Prognostic Factors for Survival. International Journal of Radiation Oncology*biology*physics 93(3): E525-E526, 2015

MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?. Journal of Neurosurgery 2018: 1-9, 2018

O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions. International Journal of Molecular Sciences 13(6): 6983-6994, 2012

Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma. Journal of Neurosurgery 125(1): 7-16, 2018

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR. Journal of Translational Medicine 10: 36, 2012

The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. Journal of Biochemistry 137(3): 431-440, 2005

Correlation between histone H3-K9 methylation, DNA methylation and expression of gene MGMT in Hep-2 cell line. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 26(21): 984-987, 2013

O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation. Plos One 6(2): E17156, 2011

MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas. Cancer Genomics and Proteomics 15(6): 437-446, 2018

Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. Journal of Biological Chemistry 269(25): 17228-17237, 1994

An Innovative Fluorescent Semi-quantitative Methylation-specific PCR Method for the Determination of MGMT Promoter Methylation is Reflecting Intra-tumor Heterogeneity. Current Cancer Drug Targets 15(7): 624-640, 2016

The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas. Neurosurgery 65(5): 866-75; Discussion 875, 2009

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma. Bmc Cancer 14: 511, 2015

MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma. Journal of Neuro-Oncology 133(3): 615-622, 2017

Real-Time Methylation-Specific Polymerase Chain Reaction for MGMT Promoter Methylation Clinical Testing in Glioblastoma: An Alternative Detection Method for a Heterogeneous Process. American Journal of Clinical Pathology 148(4): 296-307, 2017